Combat Diseases


Combat diseases that pose the greatest risk to animals and humans

Leverage the Zoetis Center for Transboundary and Emerging Diseases to develop vaccines for high-impact emerging diseases globally


Invest in R&D for emerging infectious diseases


Expanded our research capabilities for transboundary animal diseases and emerging infectious diseases.


Provide our innovative vaccines to all relevant markets via tenders or other go-to-market pathways


Supported endangered species protection programs.
Collaborated to support One Health initiatives.
California Condor - Zoetis

Emerging and Infectious Diseases

Through our Center for Transboundary and Emerging Diseases (CTED), we conduct veterinary biosurveillance and develop or support vaccines for high-impact TADs and EIDs around the world, including Avian Influenza, Porcine Epidemic Diarrhea Virus, Schmallenberg Virus, Hendra Virus, Bluetongue Virus, Lumpy Skin Disease, Canine Influenza, Rabies, Lyme disease, West Nile Virus, Avian Pneumovirus and SARS-CoV-2. 

Our scientists also organize our response to outbreaks of infectious diseases worldwide, mobilizing resources from across the company and working in close collaboration with leaders from government and health organizations, as well as veterinary and livestock agricultural communities to identify infectious disease threats early and develop solutions to help rapidly control them.

Learn More
Beef cattle farm at dusk - Zoetis

Up Next: Planet

The Drive
to Protect
Our Planet